FDA to study effect of drug-ad boasting on patient perceptions

The Wall Street Journal explains:

Time and again, consumer ads claim a medicine is the number one drug prescribed by physicians. Putting aside the question of whether such boasting is actually true, what remains unclear is the extent to which consumers view such information positively or as a substitute for effectiveness data.

And so, the FDA plans to run a pair of studies in hopes of finding an answer.

The Food and Drug Administration notice announcing the studies is here.

The full WSJ article is here.

Leave a Reply

Your email address will not be published. Required fields are marked *